ASTRAZENECA LIMITED V PHARMACEUTICAL MANAGEMENT AGENCY CA CA140/05

ASTRAZENECA LIMITED V PHARMACEUTICAL MANAGEMENT AGENCY CA CA140/05

Special leave to file an out-of-time cross-appeal was granted because the respondent promptly applied once the solicitors' mistake (reliance on revoked rules) was discovered, there was no prejudice to the appellant and the appellant did not oppose the application.

Source-derived case information.

Citation
openlaw-4e7c6592_5dd3_4219_b934_ba7018e04687.pdf
Parties
Appellant: AstraZeneca Limited; Respondent: Pharmaceutical Management Agency
Court
Court of Appeal
Jurisdiction
New Zealand
Judgment Date
18 August 2005
Procedural Posture
Civil Appeal / Application for Special Leave to Cross Appeal (out of Time Filing)
Outcome
Special leave to cross-appeal granted
Legal Topics
Special Leave, Cross Appeal, Procedural Time Limits
Civil Procedure Appeal Court Rules Special Leave Cross Appeal Procedural Time Limits

Source-derived case record

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Legal principles 3 Authorities cited 1 Party arguments 2
Sign in to unlock

Parties

AstraZeneca Limited

Appellant

Pharmaceutical Management Agency

Respondent

Procedural Posture

Civil Appeal / Application for Special Leave to Cross Appeal (out of Time Filing)

  1. 1 Whether special leave should be granted to permit an out-of-time cross-appeal
  2. 2 Whether the respondent's explanation (solicitors' reliance on revoked rules) justifies extension
  3. 3 Whether the appellant would suffer prejudice from granting leave

Ratio Decidendi

Special leave to file an out-of-time cross-appeal was granted because the respondent promptly applied once the solicitors' mistake (reliance on revoked rules) was discovered, there was no prejudice to the appellant and the appellant did not oppose the application.

Court Disposition

Special leave to cross-appeal granted

Orders

  • Respondent granted special leave to file a cross-appeal on the basis described in its application for special leave dated 2 August 2005